SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-17-098158
Filing Date
2017-03-28
Accepted
2017-03-27 21:50:03
Documents
3
Group Members
CALEB CASTELEINJAMES SHAPIROKEARNY VENTURE ASSOCIATES, L.L.C.KEARNY VENTURE PARTNERS ENTREPENEURS' FUND, L.P.RICHARD SPALDING

Document Format Files

Seq Description Document Type Size
1 SC 13D d336301dsc13d.htm SC 13D 119652
2 EX-1 d336301dex1.htm EX-1 7601
3 EX-2 d336301dex2.htm EX-2 43079
  Complete submission text file 0001193125-17-098158.txt   171978
Mailing Address 88 KEARNY ST SAN FRANCISCO CA 94108
Business Address 88 KEARNY ST SAN FRANCISCO CA 94108
Kearny Venture Partners LP (Filed by) CIK: 0001376359 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Subject) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83932 | Film No.: 17716669
SIC: 2834 Pharmaceutical Preparations